At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 72 enrolled
Drug / intervention
Dronabinol 5mg Cap +1 moredrug
Likely dose
Dronabinol 5mg Capfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cannabinoid Analgesia for Medical Abortion: A Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Dronabinol 5mg Cap and Placebo for Medical Abortion and Pain. Completed, enrolled 72 participants across 1 site.
Detailed Summary
The objective of this study is to determine if a synthetic cannabis derivative, dronabinol, in addition to ibuprofen, decreases maximum pain scores compared to ibuprofen and placebo in women undergoing medical abortion. Results of this study will help providers counsel patients regarding cannabis use during medical abortion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMedical Abortion, Pain
CountriesUnited States
CollaboratorsSociety of Family Planning
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
First PostedJul 2018
Enrollment StartNov 2018
Primary CompletionMay 2019
Study CompletionMay 2019
TodayJul 2026
First PostedJul 27, 2018
Enrollment StartNov 1, 2018
Primary CompletionMay 7, 2019
Study CompletionMay 28, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.9 years ago
Interventions
Dronabinol 5mg Capdrug
Subjects randomized to Dronabinol 5mg Cap and ibuprofen 800mg for pain
Placeboother
Subjects randomized to placebo and ibuprofen 800mg for pain